The pET Expression System: Design Logic and Selection Strategy
The pET vector series, originally developed by Novagen (now part of Merck), represents one of the most widely adopted T7-based expression platforms in Escherichia coli.
Its popularity stems not from a single superior plasmid design, but from a modular, tightly regulated, and high-output transcription system.
Mechanistic Foundation of the pET System
T7 Promoter-Driven Transcription
Target genes in pET vectors are placed under the control of the bacteriophage T7 promoter, which is recognized exclusively by T7 RNA polymerase.
Key characteristics include:
- Extremely high transcription rate
- Strong promoter specificity
- Minimal cross-recognition of host promoters
This ensures robust transcription once T7 polymerase is available.
Dual-Level Induction Mechanism
The pET system operates through a two-tier control process:
- IPTG induces expression of T7 RNA polymerase from the host chromosome (e.g., DE3 lysogen).
- T7 RNA polymerase subsequently drives transcription from the plasmid-borne T7 promoter.
This amplification mechanism accounts for the exceptionally high expression levels observed in pET systems.
Structural Modules of pET Vectors
Key functional elements include:
- T7 promoter and lac operator
- Multiple cloning site (MCS)
- Fusion tags (His, GST, MBP, Trx, SUMO, etc.)
- Protease cleavage sites
- Antibiotic resistance markers (Amp or Kan)
- pBR322-derived origin of replication
- Optional f1 origin (in "+" variants) for single-stranded DNA production
Host Dependency
pET vectors require host strains expressing T7 RNA polymerase, such as:
- BL21(DE3)
- C41(DE3)
- C43(DE3)
Standard cloning strains (e.g., DH5α) do not support expression.
Vector Selection Strategy
Selection should be guided by:
- Protein solubility
- Toxicity
- Downstream purification requirements
- Scale of production
Systematic optimization is strongly recommended for preparative-scale production.
AntibodySystem Recombinant Proteins
| Catalog | Product Name |
|---|---|
| YHJ70101 | Recombinant Human CD274/PD-L1/B7-H1 Protein, N-His |
| YHJ63901 | Recombinant Human CD93 Protein, N-GST |
| YHE07701 | Recombinant Human IL13 Protein, N-His |
| YHJ72801 | Recombinant Human IL36RN Protein, N-His |
| YHA41901 | Recombinant Human NPC1 Protein, N-His |
| YHB15401 | Recombinant Human PDCD6 Protein, N-His |
| YHG71101 | Recombinant Human PDE1C Protein, N-His |
| YHB40701 | Recombinant Human PDE5A Protein, N-His |
| YHC06301 | Recombinant Human PDGFA Protein, N-His |
| YHC33501 | Recombinant Human PDHA1 Protein, N-His |
| YHH02301 | Recombinant Human PDK1 Protein, N-His |
| YHE22001 | Recombinant Human SNCA Protein, N-His |
| YXX05601 | Recombinant Protein A/SPA Protein, C-His |
| EVV00314 | Recombinant SARS-CoV-2 RBD Protein, C-His |
| YVV02101 | Recombinant SARS-CoV-2 ORF7a/Protein U122 Protein, N-His |
